Logo image of SPNE

SEASPINE HOLDINGS CORP (SPNE) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:SPNE - US81255T1088 - Common Stock

9.54 USD
+0.73 (+8.29%)
Last: 1/4/2023, 8:00:02 PM
9.35 USD
-0.19 (-1.99%)
After Hours: 1/4/2023, 8:00:02 PM
Fundamental Rating

2

Overall SPNE gets a fundamental rating of 2 out of 10. We evaluated SPNE against 188 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of SPNE have multiple concerns. SPNE is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

SPNE had negative earnings in the past year.
SPNE had a negative operating cash flow in the past year.
SPNE Yearly Net Income VS EBIT VS OCF VS FCFSPNE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 -20M -40M -60M

1.2 Ratios

SPNE has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SPNE Yearly ROA, ROE, ROICSPNE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 -10 -20 -30

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for SPNE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SPNE Yearly Profit, Operating, Gross MarginsSPNE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 20 -20 40 -40 60

More info and screens

3

2. Health

2.1 Basic Checks

SPNE does not have a ROIC to compare to the WACC, probably because it is not profitable.
SPNE has more shares outstanding than it did 1 year ago.
SPNE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
SPNE Yearly Shares OutstandingSPNE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 10M 20M 30M
SPNE Yearly Total Debt VS Total AssetsSPNE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M

2.2 Solvency

Based on the Altman-Z score of 1.40, we must say that SPNE is in the distress zone and has some risk of bankruptcy.
SPNE has a Altman-Z score of 1.40. This is comparable to the rest of the industry: SPNE outperforms 49.08% of its industry peers.
A Debt/Equity ratio of 0.09 indicates that SPNE is not too dependend on debt financing.
SPNE's Debt to Equity ratio of 0.09 is in line compared to the rest of the industry. SPNE outperforms 53.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Altman-Z 1.4
ROIC/WACCN/A
WACC8.68%
SPNE Yearly LT Debt VS Equity VS FCFSPNE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 100M 200M 300M

2.3 Liquidity

SPNE has a Current Ratio of 3.18. This indicates that SPNE is financially healthy and has no problem in meeting its short term obligations.
SPNE has a Current ratio of 3.18. This is comparable to the rest of the industry: SPNE outperforms 44.95% of its industry peers.
A Quick Ratio of 1.65 indicates that SPNE should not have too much problems paying its short term obligations.
SPNE has a Quick ratio of 1.65. This is in the lower half of the industry: SPNE underperforms 67.89% of its industry peers.
Industry RankSector Rank
Current Ratio 3.18
Quick Ratio 1.65
SPNE Yearly Current Assets VS Current LiabilitesSPNE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 50M 100M 150M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for SPNE have decreased strongly by -20.41% in the last year.
SPNE shows a strong growth in Revenue. In the last year, the Revenue has grown by 26.03%.
The Revenue has been growing by 8.23% on average over the past years. This is quite good.
EPS 1Y (TTM)-20.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.5%
Revenue 1Y (TTM)26.03%
Revenue growth 3Y10.11%
Revenue growth 5Y8.23%
Sales Q2Q%44.57%

3.2 Future

The Earnings Per Share is expected to grow by 2.06% on average over the next years.
SPNE is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.60% yearly.
EPS Next Y-1.82%
EPS Next 2Y8.56%
EPS Next 3Y11.83%
EPS Next 5Y2.06%
Revenue Next Year24.57%
Revenue Next 2Y17.4%
Revenue Next 3Y16.89%
Revenue Next 5Y11.6%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SPNE Yearly Revenue VS EstimatesSPNE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M
SPNE Yearly EPS VS EstimatesSPNE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 -1 -2 -3

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

SPNE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SPNE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SPNE Price Earnings VS Forward Price EarningsSPNE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SPNE Per share dataSPNE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y8.56%
EPS Next 3Y11.83%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SPNE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SEASPINE HOLDINGS CORP

NASDAQ:SPNE (1/4/2023, 8:00:02 PM)

After market: 9.35 -0.19 (-1.99%)

9.54

+0.73 (+8.29%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-01 2022-11-01/amc
Earnings (Next)03-09 2023-03-09
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners6.42%
Ins Owner Change0%
Market Cap354.91M
Revenue(TTM)229.75M
Net Income(TTM)-64.84M
Analysts85.71
Price Target16.13 (69.08%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-20.48%
Min EPS beat(2)-35%
Max EPS beat(2)-5.95%
EPS beat(4)0
Avg EPS beat(4)-27.95%
Min EPS beat(4)-47.45%
Max EPS beat(4)-5.95%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)0.92%
Min Revenue beat(2)0.23%
Max Revenue beat(2)1.61%
Revenue beat(4)3
Avg Revenue beat(4)0.68%
Min Revenue beat(4)-0.65%
Max Revenue beat(4)1.61%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.54
P/FCF N/A
P/OCF N/A
P/B 1.29
P/tB 2.31
EV/EBITDA N/A
EPS(TTM)-1.77
EYN/A
EPS(NY)-1.33
Fwd EYN/A
FCF(TTM)-2.16
FCFYN/A
OCF(TTM)-1.22
OCFYN/A
SpS6.18
BVpS7.38
TBVpS4.12
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 212.78%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.18
Quick Ratio 1.65
Altman-Z 1.4
F-Score3
WACC8.68%
ROIC/WACCN/A
Cap/Depr(3y)159.81%
Cap/Depr(5y)125.57%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-20.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.5%
EPS Next Y-1.82%
EPS Next 2Y8.56%
EPS Next 3Y11.83%
EPS Next 5Y2.06%
Revenue 1Y (TTM)26.03%
Revenue growth 3Y10.11%
Revenue growth 5Y8.23%
Sales Q2Q%44.57%
Revenue Next Year24.57%
Revenue Next 2Y17.4%
Revenue Next 3Y16.89%
Revenue Next 5Y11.6%
EBIT growth 1Y-27.4%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year71.08%
EBIT Next 3Y25.82%
EBIT Next 5Y14.6%
FCF growth 1Y-150.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-136.29%
OCF growth 3YN/A
OCF growth 5YN/A

SEASPINE HOLDINGS CORP / SPNE FAQ

What is the fundamental rating for SPNE stock?

ChartMill assigns a fundamental rating of 3 / 10 to SPNE.


What is the valuation status for SPNE stock?

ChartMill assigns a valuation rating of 2 / 10 to SEASPINE HOLDINGS CORP (SPNE). This can be considered as Overvalued.


What is the profitability of SPNE stock?

SEASPINE HOLDINGS CORP (SPNE) has a profitability rating of 1 / 10.


How financially healthy is SEASPINE HOLDINGS CORP?

The financial health rating of SEASPINE HOLDINGS CORP (SPNE) is 4 / 10.